Health News

Advanced Prostate Cancer Rx Approved
When cancer begins to spread from its original site, the bones are a common destination. Now, men with advanced prostate cancer have a new option that may help them live longer.
FDA approves Simponi
The U.S. Food and Drug Administration today approved a new use for Simponi (golimumab) injection to treat adults with moderate to severe ulcerative colitis.
Head Injuries May Hike Military Suicides
Trying to remain mentally well is one of the most serious challenges facing military servicemen and women who are on the battlefront and veterans at home.
Not Your Garden Variety Skin Cancer
Skin cancers that are not melanoma are typically curable. A common type of skin cancer, though, can spread and become lethal, new research has found.
Middle Age: Not Too Late for Fitness
If you’re middle-aged and feeling unfit, you can still benefit from exercise. The American Heart Association says if you get moving at 40 or older, you can reduce heart failure risk.
The Dream of an HIV Vaccine
Imagine a world where HIV/AIDS is no longer a major health concern – and not because of a cure for the disease but due to  prevention of the disease before it even strikes. That is the dream for many researchers and health workers focused on fighting HIV.
Rx That Put a Wrench in the Works
Several medications that help with common ailments could contain chemicals that get in the way of memory function. Communicating about these risks with a healthcare provider may help improve safety.
Ticking a Lyme Disease Vaccine Off The List
Finding a tick can be a nerve-racking experience, as concerns about Lyme disease are well known, especially to those living in rural areas. But what if people could know they are protected and simply shrug these encounters off?
The Many Faces of Anemia
Feeling a little tired at the end of your day is normal. But if you've been feeling exhausted for weeks or months on end, even after what seemed like a good night's rest, you could have a blood disorder known as anemia.
FDA Approves New Rx, Xofigo
The US Food and Drug Administration today approved Xofigo (radium Ra 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones but not to other organs.